Cutaneous Oncology News

Be sure to check out Healio Dermatology’s live coverage from the American Society for Dermatologic Surgery annual meeting.

CHICAGO — In patients with advanced cutaneous squamous cell carcinoma, a multidisciplinary discussion on treatment options should include oncologists, radiation oncologists and the primary care physician in weighing risks and benefits to various approaches, according to Todd Schlesinger, MD, FAAD, FASMS, medical director at Dermatology and Laser Center of Charleston.

CHICAGO — Deploying artificial intelligence in the dermatology practice will help bring more humanity back and lead to more engaged and satisfied patients, Justin Ko, MD, MBA, director and chief of medical dermatology at Stanford Health Care, said here at the American Society for Dermatologic Surgery annual meeting.

CHICAGO — Dermatologists have multiple ways to approach high-risk basal cell carcinomas — not every case must be treated with Mohs micrographic surgery nor sent to a radiation oncologist, according to Marc Brown, MD, professor of dermatology and oncology director at University of Rochester Medical Center and president-elect of the American Society for Dermatologic Surgery.

CHICAGO — Biopsy alone detects fewer aggressive subtypes of basal cell carcinoma of the ear compared with Mohs histopathology, according to data presented here at the American Society for Dermatologic Surgery annual meeting.

CHICAGO — In an educational session here at the American Society for Dermatologic Surgery annual meeting, Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, provided an update on squamous cell carcinoma, including how to prevent patients from entering the high-risk category and available treatment options.

CHICAGO — For world-renowned chef Grant Achatz, attaining the title of best restaurant in America by Gourmet Magazine was his second greatest challenge compared with fighting the stage IV tongue cancer which nearly cost him his life.

In Korean patients, male sex and Breslow thickness greater than 2.5 mm are the most important prognostic factors for localized melanoma recurrence, according research in Journal of the American Academy of Dermatology.

Dermatology is gearing up for the upcoming South Beach Symposium in Miami Beach, Florida, Feb. 6-9, 2020.

After undergoing surgery at a dermatologic surgery cancer center, patients had significantly less worry regarding cancer recurrence and its impact on daily life.